

Shares of Ocugen are remaining flat Thursday morning as investors continue to weigh disappointing interim clinical trial data.
You can purchase shares of Ocugen (NASDAQ:OCGN) through any online brokerage.
Other companies in Ocugen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Ocugen has a consensus price target of $8.30.
The stock price for Ocugen (NASDAQ: OCGN) is $0.7389 last updated November 2, 2026 at 7:45 PM EST.
There are no upcoming dividends for Ocugen.
Ocugen does not have any upcoming earnings scheduled.
There is no upcoming split for Ocugen.
Ocugen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform,...